Compare Citra Putra Realty Tbk. (CLAY) vs Diagnos Laboratorium Utama Tbk. (DGNS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citra Putra Realty Tbk. vs Diagnos Laboratorium Utama Tbk. — how do they compare? Citra Putra Realty Tbk. trades at Rp2,520 (market cap 6.48T), while Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 308B). The key difference: Citra Putra Realty Tbk. is far larger — about 21× Diagnos Laboratorium Utama Tbk.'s market cap. Which is the better fit depends on your goals.
| CLAY | DGNS | |
|---|---|---|
Market Cap | 6.48T | 308B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Citra Putra Realty Tbk.
PT Citra Putra Realty Tbk (“The Entity”) was established based on Notarial Deed of Herlina Pakpahan, S.H., No. 09 dated December 16, 2009. The majority shareholders (parent entity) of the Entity are PT Citra Putra Mandiri or better known as the OSO Group.
Read more on CLAY →About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →
